Cite
HARVARD Citation
Marques-Piubelli, M. et al. (2021). Expression of BCL2 alternative proteins and association with outcome in CLL patients treated with venetoclax. Leukemia & lymphoma. 62 (5), pp. 1129-1135. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Marques-Piubelli, M. et al. (2021). Expression of BCL2 alternative proteins and association with outcome in CLL patients treated with venetoclax. Leukemia & lymphoma. 62 (5), pp. 1129-1135. [Online].